We are live on ! Find out more
MGNX icon

MacroGenics
MGNX

132 hedge funds and large institutions have $835M invested in MacroGenics in 2016 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 36 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,075% more call options, than puts

Call options by funds: $2.77M | Put options by funds: $236K

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

31% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 36

10% more capital invested

Capital invested by funds: $760M → $835M (+$75.2M)

6% more funds holding

Funds holding: 125 → 132 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
132
Holders Change
+7
Holders Change %
+5.6%
% of All Funds
3.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
47
Reduced
36
Closed
9
Calls
$2.77M
Puts
$236K
Net Calls
+$2.54M
Net Calls Change
+$1.81M

Top Buyers

Rank Fund Capital Flow
1
BB
BB Biotech
Switzerland
+$27.8M
2
HRCM
Hood River Capital Management
Florida
+$5.63M
3
AG
Artal Group
Luxembourg
+$4.46M
4
SIM
Spark Investment Management
New York
+$3.71M
5
Millennium Management
Millennium Management
New York
+$3.59M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$22.1M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$13.1M
3
BI
BVF Inc
California
-$5.4M
4
O
OrbiMed
New York
-$4.03M
5
JP Morgan Chase
JP Morgan Chase
New York
-$3.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
51
DAFNA Capital Management
California
$1.62M – – –
PNC Financial Services Group
52
PNC Financial Services Group
Pennsylvania
$1.6M +$1.59M +53,459 +38,460%
CCMH
53
Cornerstone Capital Management Holdings
New York
$1.56M +$1.36M +45,600 +691%
Invesco
54
Invesco
Georgia
$1.45M +$799K +26,857 +125%
CIA
55
Capital Impact Advisors
Massachusetts
$1.43M – – –
AA
56
ALPS Advisors
Colorado
$1.32M -$126K -4,251 -9%
EOJOAM
57
E. Ohman J:or Asset Management
Sweden
$1.31M +$1.31M +43,935 New
Swiss National Bank
58
Swiss National Bank
Switzerland
$1.3M -$41.6K -1,400 -3%
AllianceBernstein
59
AllianceBernstein
Tennessee
$1.3M -$17.8K -600 -1%
Macquarie Group
60
Macquarie Group
Australia
$1.2M -$1.19M -40,000 -50%
SFI
61
SPC Financial Inc
Maryland
$1.13M – – –
GC
62
Globeflex Capital
California
$1.1M -$2.97K -100 -0.3%
CS
63
Credit Suisse
Switzerland
$1.09M +$113K +3,801 +12%
RhumbLine Advisers
64
RhumbLine Advisers
Massachusetts
$1.02M +$27.8K +935 +3%
Goldman Sachs
65
Goldman Sachs
New York
$1.01M +$605K +20,348 +151%
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
$1.01M +$84.2K +2,831 +9%
Deutsche Bank
67
Deutsche Bank
Germany
$913K -$853K -28,681 -48%
DCM
68
Dupont Capital Management
Delaware
$801K +$796K +26,768 New
Royal Bank of Canada
69
Royal Bank of Canada
Ontario, Canada
$797K +$363K +12,200 +85%
VIA
70
Vident Investment Advisory
Georgia
$795K -$26.8K -900 -3%
TCM
71
Tanaka Capital Management
New York
$783K – – –
EA
72
Emerald Acquisition
Washington
$780K +$776K +26,079 New
ProShare Advisors
73
ProShare Advisors
Maryland
$749K -$136K -4,570 -15%
BA
74
BlackRock Advisors
Delaware
$743K +$154K +5,180 +26%
DAM
75
Doheny Asset Management
California
$694K – – –
1 2
3
4 5

MGNX Hedge Fund Activity: Q3 2016 in Review

132 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2016, worth a combined $835M — up 9.9% from $760M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new MGNX positions and 9 closed out — a net gain of 8 holders — while 47 added to existing stakes and 36 trimmed.

The largest buyer was BB Biotech, adding an estimated $27.8M. The largest seller was Point72 Asset Management, cutting an estimated $22.1M.

  • 132 institutional investors held MacroGenics (MGNX) as of Q3 2016, up from 125 in Q2 2016.
  • Funds reported $835M of MacroGenics stock for Q3 2016, up 9.9% quarter-over-quarter.
  • 17 funds opened new MacroGenics positions in Q3 2016 and 9 closed out, a net change of +8 holders.
  • The largest MacroGenics buyer in Q3 2016 was BB Biotech, an estimated $27.8M added.
  • The largest MacroGenics seller in Q3 2016 was Point72 Asset Management, an estimated $22.1M sold.

Based on aggregated 13F filings for Q3 2016.